Valvular heart disease, pulmonary hypertension, and fenfluramine/phentermine use

Charles J Bruce, H. M. Connolly

Research output: Contribution to journalArticle

Abstract

Recent findings leading to the reported association of fenfluramine and phentermine use with valvular abnormalities and pulmonary hypertension are discussed. The authors provide current American Heart Association and United States Department of Health and Human Services guidelines for the evaluation and treatment of patients exposed to these agents.

Original languageEnglish (US)
Pages (from-to)17-19
Number of pages3
JournalCardiology Review
Volume15
Issue number11
StatePublished - 1998

Fingerprint

Phentermine
United States Dept. of Health and Human Services
Fenfluramine
Heart Valve Diseases
Pulmonary Hypertension
Guidelines
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Valvular heart disease, pulmonary hypertension, and fenfluramine/phentermine use. / Bruce, Charles J; Connolly, H. M.

In: Cardiology Review, Vol. 15, No. 11, 1998, p. 17-19.

Research output: Contribution to journalArticle

@article{91df30d2578b44fa8712a2d7e3fd09bc,
title = "Valvular heart disease, pulmonary hypertension, and fenfluramine/phentermine use",
abstract = "Recent findings leading to the reported association of fenfluramine and phentermine use with valvular abnormalities and pulmonary hypertension are discussed. The authors provide current American Heart Association and United States Department of Health and Human Services guidelines for the evaluation and treatment of patients exposed to these agents.",
author = "Bruce, {Charles J} and Connolly, {H. M.}",
year = "1998",
language = "English (US)",
volume = "15",
pages = "17--19",
journal = "Cardiology Board Review",
issn = "1092-6607",
publisher = "Ascend Media",
number = "11",

}

TY - JOUR

T1 - Valvular heart disease, pulmonary hypertension, and fenfluramine/phentermine use

AU - Bruce, Charles J

AU - Connolly, H. M.

PY - 1998

Y1 - 1998

N2 - Recent findings leading to the reported association of fenfluramine and phentermine use with valvular abnormalities and pulmonary hypertension are discussed. The authors provide current American Heart Association and United States Department of Health and Human Services guidelines for the evaluation and treatment of patients exposed to these agents.

AB - Recent findings leading to the reported association of fenfluramine and phentermine use with valvular abnormalities and pulmonary hypertension are discussed. The authors provide current American Heart Association and United States Department of Health and Human Services guidelines for the evaluation and treatment of patients exposed to these agents.

UR - http://www.scopus.com/inward/record.url?scp=0032449299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032449299&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032449299

VL - 15

SP - 17

EP - 19

JO - Cardiology Board Review

JF - Cardiology Board Review

SN - 1092-6607

IS - 11

ER -